UK regulator says some evidence AstraZeneca clots occur more in women than men By Reuters
LONDON (Reuters) - Britain's medicine regulator on Thursday said there was some evidence that uncommon blood clots linked to AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine occurred more in women than in men, adding that the difference in incidence was small. British officials have previously only said that the incidence of the clots was linked to age, and that a link with sex had not been established, noting that more women had been vaccinated then men. "There is now some evidence that the reported incidence rate is higher in females compared to men although this is not seen across...
Continue reading